Salpie leads BacTbio's vision and strategy, holding a PhD in Computational Biology from King's College London and 12 years of research experience in computational analysis and the modelling of complex biological systems. Salpie's focus is translating cutting-edge microbiome and gut–liver-axis science into products that reach people at the stage where they can benefit most.
Max heads the science and engineering behind BacTbio's next-generation probiotic platform. He holds a PhD in Molecular Biology from Heidelberg University and brings 19 years of research experience in molecular genetics, engineering and lead-molecule technology development — designing living therapeutics built to work with the body's own biology rather than override it.
Gabriel guides BacTbio's clinical and medical strategy. A medical doctor (MB ChB, University of Manchester) with 10 years of clinical experience, he has recruited and monitored patients on a Phase III trial and led the implementation of a novel diagnostic tool in major hospitals — keeping the science grounded in real patient need and rigorous, peer-reviewed evidence.